Kołacińska and colleagues examined the expression level of several selected genes, including CASP3, using the real-time PCR method in patients with various molecular subtypes of breast cancer (including 17 patients with TNBC) not subjected to neoadjuvant chemotherapy compared to control samples taken from patients without cancer. Here, CASP3 is linked to breast cancer.